Cryocell International Stock Technical Analysis
| CCEL Stock | USD 3.43 0.06 1.78% |
As of the 16th of February 2026, CryoCell International shows the Standard Deviation of 3.08, mean deviation of 2.14, and Risk Adjusted Performance of (0.07). CryoCell International technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm CryoCell International market risk adjusted performance, variance, as well as the relationship between the Variance and value at risk to decide if CryoCell International is priced correctly, providing market reflects its regular price of 3.43 per share. Given that CryoCell International has information ratio of (0.11), we suggest you to validate CryoCell International's prevailing market performance to make sure the company can sustain itself at a future point.
CryoCell International Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as CryoCell, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CryoCellCryoCell International's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.CryoCell International Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 8.5 | Buy | 1 | Odds |
Most CryoCell analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand CryoCell stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of CryoCell International, talking to its executives and customers, or listening to CryoCell conference calls.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CryoCell International. Projected growth potential of CryoCell fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive CryoCell International assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.31) | Dividend Share 0.65 | Earnings Share (0.06) | Revenue Per Share | Quarterly Revenue Growth (0.03) |
Investors evaluate CryoCell International using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating CryoCell International's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause CryoCell International's market price to deviate significantly from intrinsic value.
It's important to distinguish between CryoCell International's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CryoCell International should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, CryoCell International's market price signifies the transaction level at which participants voluntarily complete trades.
CryoCell International 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CryoCell International's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CryoCell International.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in CryoCell International on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding CryoCell International or generate 0.0% return on investment in CryoCell International over 90 days. CryoCell International is related to or competes with BioAffinity Technologies, Artelo Biosciences, Revelation Biosciences, WORK Medical, GT Biopharma, Psyence Biomedical, and Protagenic Therapeutics. Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the coll... More
CryoCell International Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CryoCell International's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CryoCell International upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 16.21 | |||
| Value At Risk | (4.94) | |||
| Potential Upside | 4.71 |
CryoCell International Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for CryoCell International's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CryoCell International's standard deviation. In reality, there are many statistical measures that can use CryoCell International historical prices to predict the future CryoCell International's volatility.| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.30) | |||
| Total Risk Alpha | (0.52) | |||
| Treynor Ratio | (2.10) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of CryoCell International's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
CryoCell International February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | (2.09) | |||
| Mean Deviation | 2.14 | |||
| Coefficient Of Variation | (1,110) | |||
| Standard Deviation | 3.08 | |||
| Variance | 9.46 | |||
| Information Ratio | (0.11) | |||
| Jensen Alpha | (0.30) | |||
| Total Risk Alpha | (0.52) | |||
| Treynor Ratio | (2.10) | |||
| Maximum Drawdown | 16.21 | |||
| Value At Risk | (4.94) | |||
| Potential Upside | 4.71 | |||
| Skewness | (0.48) | |||
| Kurtosis | 2.31 |
CryoCell International Backtested Returns
CryoCell International secures Sharpe Ratio (or Efficiency) of -0.0755, which signifies that the company had a -0.0755 % return per unit of risk over the last 3 months. CryoCell International exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm CryoCell International's Standard Deviation of 3.08, risk adjusted performance of (0.07), and Mean Deviation of 2.14 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.14, which signifies not very significant fluctuations relative to the market. As returns on the market increase, CryoCell International's returns are expected to increase less than the market. However, during the bear market, the loss of holding CryoCell International is expected to be smaller as well. At this point, CryoCell International has a negative expected return of -0.24%. Please make sure to confirm CryoCell International's value at risk, accumulation distribution, as well as the relationship between the Accumulation Distribution and day typical price , to decide if CryoCell International performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.55 |
Modest predictability
CryoCell International has modest predictability. Overlapping area represents the amount of predictability between CryoCell International time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CryoCell International price movement. The serial correlation of 0.55 indicates that about 55.0% of current CryoCell International price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.55 | |
| Spearman Rank Test | 0.25 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
CryoCell International technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
CryoCell International Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of CryoCell International volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About CryoCell International Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of CryoCell International on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of CryoCell International based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on CryoCell International price pattern first instead of the macroeconomic environment surrounding CryoCell International. By analyzing CryoCell International's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of CryoCell International's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to CryoCell International specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | Dividend Yield | 0.0258 | 0.0245 | Price To Sales Ratio | 2.53 | 2.41 |
CryoCell International February 16, 2026 Technical Indicators
Most technical analysis of CryoCell help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for CryoCell from various momentum indicators to cycle indicators. When you analyze CryoCell charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | (2.09) | |||
| Mean Deviation | 2.14 | |||
| Coefficient Of Variation | (1,110) | |||
| Standard Deviation | 3.08 | |||
| Variance | 9.46 | |||
| Information Ratio | (0.11) | |||
| Jensen Alpha | (0.30) | |||
| Total Risk Alpha | (0.52) | |||
| Treynor Ratio | (2.10) | |||
| Maximum Drawdown | 16.21 | |||
| Value At Risk | (4.94) | |||
| Potential Upside | 4.71 | |||
| Skewness | (0.48) | |||
| Kurtosis | 2.31 |
CryoCell International February 16, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as CryoCell stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.04 | ||
| Daily Balance Of Power | 0.46 | ||
| Rate Of Daily Change | 1.02 | ||
| Day Median Price | 3.37 | ||
| Day Typical Price | 3.39 | ||
| Price Action Indicator | 0.10 | ||
| Market Facilitation Index | 0.13 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CryoCell International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in discontinued. For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CryoCell International. Projected growth potential of CryoCell fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive CryoCell International assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.31) | Dividend Share 0.65 | Earnings Share (0.06) | Revenue Per Share | Quarterly Revenue Growth (0.03) |
Investors evaluate CryoCell International using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating CryoCell International's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause CryoCell International's market price to deviate significantly from intrinsic value.
It's important to distinguish between CryoCell International's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CryoCell International should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, CryoCell International's market price signifies the transaction level at which participants voluntarily complete trades.